Advertisement

Reactions Weekly

, Volume 1722, Issue 1, pp 11–11 | Cite as

Systematic review: baricitinib in rheumatoid arthritis

Clinical study
  • 17 Downloads

Reference

  1. Huang F, et al. Risk of Adverse Drug Events Observed with Baricitinib 2 mg Versus Baricitinib 4 mg Once Daily for the Treatment of Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. BioDrugs : 10 Sep 2018. Available from: URL: http://doi.org/10.1007/s40259-018-0304-3

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations